Hi everyone, have been reading for a while here but now I also want to contribute a bit when possible. I've started an own company earlier this year after having worked in two Big Pharma for the last >5 years. So if you want information around that feel free to ask, I'll be happy to help further if possible!
-
-
Hey
good to know. What are doing in your company in detail? -
Thanks for your answer :-)
Longterm vision is to develop a software package bringing Pharmacogenomics applications into Healthcare, shortterm it is about providing Bioinformatics services at the "Interface" of human genetics and drug information (see e.g. http://de.slideshare.net/jscheiber/f...variance-aug12)Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment